Cancer of the prostate: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- PMID: 26205393
- DOI: 10.1093/annonc/mdv222
Cancer of the prostate: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Erratum in
-
The ESMO Guidelines Committee would like to publish the following corrections to manuscripts published in 2015.Ann Oncol. 2016 Sep;27(Suppl 5):v148. doi: 10.1093/annonc/mdw353. Ann Oncol. 2016. PMID: 27664257 No abstract available.
Comment in
-
Many men with castrate-sensitive metastatic prostate cancer should not receive chemotherapy.Ann Oncol. 2016 Mar;27(3):545-6. doi: 10.1093/annonc/mdv600. Epub 2015 Dec 12. Ann Oncol. 2016. PMID: 26659397 No abstract available.
-
Reply to the letter to the editor 'Many men with castrate-sensitive metastatic prostate cancer should not receive chemotherapy' by Tannock et al.Ann Oncol. 2016 Apr;27(4):750-1. doi: 10.1093/annonc/mdw023. Epub 2016 Jan 22. Ann Oncol. 2016. PMID: 26802159 No abstract available.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
